HLA-G and neoplasm: Thus, HLA-G is capable of inhibiting all actors of anti-tumor responses and in contrast to both CTLA-4 and PD-1, of blocking all stages of such an anti-tumor response, from the APC activation and effector priming, to the function of a fully activated cytotoxic T cell or NK cell.